OTC Labeling Implementation Date Extended One Year
This article was originally published in The Tan Sheet
Executive Summary
FDA is extending the OTC drug labeling implementation date to May 2002 to allow time for the agency to develop "forthcoming guidances" regarding a number of outstanding industry concerns.
You may also be interested in...
OTC Labeling Rule General Deferral For Convenience-Size Drugs To Be Issued
FDA will publish a notice to "delay the compliance date of the current Drug Facts rules with respect to 'convenience-size' drug packages" in an upcoming issue of the Federal Register
Combo OTC Drug Labeling Deadlines To Be Addressed In Final Monographs
FDA will take into account OTC labeling reg compliance deadlines when publishing final monographs that could subject combination products to frequent relabeling, the agency says in a June 20 Federal Register notice extending by one year implementation provisions for specific types of OTCs.
Pepcid AC Gelcaps Sample Pouch Deferral Granted Without "Drug Facts" Title
J&J/Merck's request for a nine-month deferral from complying with the OTC labeling format for sample pouches of the company's H2 antagonist Pepcid AC Gelcaps has been granted.